Back to Journals » Cancer Management and Research » Volume 13

Silenced Myeloblastosis Protein Suppresses Oral Tongue Squamous Cell Carcinoma via the microRNA-130a/Cylindromatosis Axis [Retraction]

Authors Yang R, Shui Y, Hu S, Zhang K, Wang Y, Peng Y 

Received 21 October 2021

Accepted for publication 21 October 2021

Published 26 October 2021 Volume 2021:13 Pages 8059—8060

DOI https://doi.org/10.2147/CMAR.S345536



Yang R, Shui Y, Hu S, Zhang K, Wang Y, Peng Y. Cancer Manag Res. 2020;12:6935–6946.

At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published paper. Following publication, the authors learned that the OTSCC cell lines described in the article had not been isolated from patient tissue samples but had in fact been cultured for several generations in a public lab prior to being used in the study. Thus, the authors have determined the study does not reliably indicate the results of patients with the type of cancer classification described, and the conclusions of the study are invalid.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.